Improving Resilience and Equity in Breast Cancer Screening: Lessons from COVID-19 and Beyond
Agenda
November 16, 2020
|
1:00-1:10 |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process |
|
1:10 – 2:00 |
PCP Working Group Introduction and Presentation PCP introduction, introduce the working team and present work to date on the landscape of opportunities, barriers, and possible solutions |
|
2:00 – 3:00 |
Breast Cancer Screening Improvement Opportunities Session 1: Genetic Testing Expansion and Risk-Based Screening Opportunities to improve screening, associated barriers, and possible solutions
|
|
3:00 – 3:15 |
Break |
|
3:15 – 4:15 |
Breast Cancer Screening Improvement Opportunities Session 2: Work to Eliminate Disparities in Screening Opportunities to improve screening, associated barriers, and possible solutions |
|
4:15 – 4:35 |
Working Group Review of Input and Final Comments Review of the day’s stakeholder input and reactions to day’s work |
|
4:35 – 5:00 |
Response to Public Questions and Comments |
November 18, 2020
|
1:00-1:15 |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process, reflections from day 1 |
|
1:15 – 2:00 |
Breast Cancer Screening Improvement Opportunities Session 3: Alignment of Multiple Screening Guidelines Opportunities to improve screening, associated barriers, and possible solutions |
|
2:00 – 2:45 |
Breast Cancer Screening Improvement Opportunities Session 4: Perception Opportunities to improve screening, associated barriers, and possible solutions |
|
2:45 – 3:00 |
Break |
|
3:00 – 4:30 |
Cross-Cutting Theme Review Review of the barriers falling into each cross-cutting theme, identification of any missing barriers
|
|
4:30 – 4:40 |
Panel Final Comments Brief review of input and panel discussion of next steps |
|
4:40 – 5:00 |
Response to Public Questions and Comments |